Glyca
A guardian angel for Type 1

Privacy Notice

Version v2026-05-06.3 · Last updated: 6 May 2026

Draft v0 — not legal advice; pending counsel review. This document is being prepared during the closed beta. It will be formally reviewed by a Belgian data-protection lawyer before public launch. We publish it now so users can see what we do with their data.

1. Who we are

Glyca is operated by Satish Singh (Antwerp, Belgium) acting as the data controller under GDPR Article 4(7). For any data-protection question — exercising your rights, withdrawing consent, reporting a concern — write to satixbv@outlook.com.

2. What data we process

3. Why we process it (purposes & lawful basis)

4. Who we share it with (sub-processors)

We use a small number of third-party services to run Glyca. Each processes data only on documented instructions from us, has a Data Processing Agreement on file (or its terms apply), and was selected with EU data-protection compliance in mind. The categories of recipient are listed below; we don't publish the specific vendor names here so as not to expose our infrastructure choices, but we'll send you the named list on request to satixbv@outlook.com.

5. How long we keep your data

6. Your rights (GDPR Articles 15–22)

You have the right to:

To exercise these rights, email satixbv@outlook.com. Self-service export and deletion endpoints are coming in Phase 1 — until then we'll process your request within 30 days of receiving it.

You also have the right to lodge a complaint with the Belgian data-protection authority (Gegevensbeschermingsautoriteit / Autorité de protection des données): www.dataprotectionauthority.be.

7. International data transfers

Some of our sub-processors (LLM provider, application hosting, DNS & CDN provider) host infrastructure in the United States. Where personal data is transferred outside the EU/EEA, we rely on Standard Contractual Clauses (Commission Decision 2021/914) to provide GDPR-equivalent protection. The bulk of your health data stays in the EU (Frankfurt). The LLM narration step sends a compact, non-time-series evidence summary — no raw glucose trace — across the SCC-protected channel.

8. Automated processing & AI disclosure

Glyca uses a Large Language Model (a generative-AI service provided by a third party — full name available on request) to compose the prose portions of the morning brief, evening summary, and weekly endo report. The model receives a structured summary of your data and produces narrative text. It is automatically blocked from giving dosing advice or recommending pump-setting changes by a banned-phrase filter. No automated decisions are made that produce legal effects on you within the meaning of GDPR Article 22 — every output is presented as a discussion point for you and your clinician.

9. Security

CGM passwords are encrypted at rest in a managed secrets vault. Database row-level security restricts cross-user reads. Service- role keys stay on the server; no client ever sees them. Sub-processor connections are TLS-only.

10. Changes to this notice

If we materially change how we process your data, we will bump this document's version, post the new text, and (where required) ask you to re-consent before continuing.

See also: Terms of Service.